IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Citius Oncology Inc (CTOR)

CUSIP: 17331Y109 | NYSE | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 35 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AArmistice Capital, LLC9,353,55310.0%New 5%+ stakeJun 30, 2026No 13F filer matched
13D/ACitius Pharmaceuticals, Inc.66,049,61571.0%UnchangedMay 15, 2026

Institutional Holders — Q3 2026

Geode Capital Management, LLC281,929
0.0% of portfolio›$284.7K
IFP Advisors, Inc107,424
0.0% of portfolio›$108.5K
Private Advisor Group, LLC25,000
0.0% of portfolio›$25.3K
UBS Group AG13,982
0.0% of portfolio›$14.1K
StoneX Group Inc.13,719
0.0% of portfolio›$12.3K
Caitong International Asset Management Co., Ltd1
0.0% of portfolio›$1
Citigroup Inc1
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Geode Capital Management, LLC
281,929$284.7K0.0%IndexVery LowBoston, MA2026-11-06
IFP Advisors, Inc
107,424$108.5K0.0%CoreLowTampa, FL2026-10-16
Private Advisor Group, LLC
25,000$25.3K0.0%ETFMediumMorristown, NJ2026-11-10
UBS Group AG
13,982$14.1K0.0%CoreMediumZurich, Switzerland2026-11-10
StoneX Group Inc.
13,719$12.3K0.0%ETFMediumNew York, NY2026-11-03
Caitong International Asset Management Co., Ltd
1$10.0%GrowthVery HighHong Kong, South Korea2026-10-29
Citigroup Inc
1$10.0%CoreMediumNew York, NY2026-11-04
No 13F filer matched
13G/AArmistice Capital, LLC9,353,553
10.0% of class · Jun 30, 2026New 5%+ stake
No 13F filer matched
13D/ACitius Pharmaceuticals, Inc.66,049,615
71.0% of class · May 15, 2026Unchanged
No 13F filer matched